Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Gasser R, Ablasser K, Roessl U, Kraigher-Krainer E, Lewinski D, Mangge H, Mächler H, Trantina-Yates A, Tscheliessnigg KH, Udermann H, Porta S, Friehs I, Scherr E, Brussee H, Gasser S
Differential Gene Expression und Nebivolol and Atenolol during Experimental Ischemia in Human Myocardium
Journal of Clinical and Basic Cardiology 2008; 11 (1-4): 16-23

PDF    Summary    Overview   

First Image Fig. 2: Atenolol - Nebivolol Fig. 3: Hypoxia Fig. 4: Nebivolol - Atenolol This Image - Fig. 5: Nebivolol - Atenolol Fig. 6: Biochemical process Fig. 7: Well-oxygenized preparations Fig. 8: Gene expression Last Image
Figure/Graphic 5: Nebivolol - Atenolol
Similarly, as in Figure 4, biological processes involved in cell-mediated immunity and reverse transcription are significantly up-regulated by nebivolol and not by atenolol. One may deduce that both cellular immunity as well as reverse transcription are regulated by nebivolol at various sites.
 
Nebivolol - Atenolol
Previous Image Next Image   


Figure/Graphic 5: Nebivolol - Atenolol
Similarly, as in Figure 4, biological processes involved in cell-mediated immunity and reverse transcription are significantly up-regulated by nebivolol and not by atenolol. One may deduce that both cellular immunity as well as reverse transcription are regulated by nebivolol at various sites.
 
copyright © 2000–2026 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung